Normal Organoid

Skin & Hair Folicle Organoid

Skin & Hair organoids replicate the complex structure of hair follicles, allowing detailed studies of hair growth and regeneration. ▶ Replicate hair follicle structure for studying growth, regeneration.
They enable modeling of hair disorders such as alopecia, providing insights into disease mechanisms and potential therapeutic strategies. ▶ Model alopecia, explore disease mechanisms, therapeutic strategies.
Skin & hair organoids serve as effective models for testing the efficacy and safety of hair growth-promoting drugs and treatments. ▶ Test skin& hair growth drugs' efficacy, safety effectively in models.


Organism
Product Type	Organoid
Tissue	iPSC
Disease

Applications

Whitening efficacy

Monitor the long-term efficacy of whitening treatments to develop superior products based on your observations.

Anti-aging efficacy

Observe the long-term anti-aging efficacy using live cells to develop superior products

Skin toxicity

Verify skin toxicity using three-dimensional organoids. Observe toxicity and improvements from UV exposure and drug treatments

Hair growth efficacy

Verify the visible number of hairs and hair length to ensure superior product performance

Hair loss prevention efficacy

Develop hair loss improvement drugs using our advanced hair loss model.

Normal Organoid

Intestinal Organoid

Intestinal organoids exhibit diverse cell types found in the human intestine, enabling detailed cellular studies. ▶ Exhibit diverse intestinal cell types, enable detailed cellular studies.
They can model various intestinal diseases, providing insights into disease mechanisms and potential treatments. ▶ Model intestinal diseases, offer insights into mechanisms, treatments.
Intestinal organoids serve as effective models for testing drug efficacy and toxicity relevant to gastrointestinal conditions. ▶ Effective models for testing drug efficacy, toxicity in gastrointestinal conditions.


Organism
Product Type	Organoid
Tissue	PSC, Intestinal tissue
Disease

Applications

Inflammatory bowel disease (3D)

Inflammatory Bowel Disease (IBD) refers to a chronic condition characterized by inflammation within the gastrointestinal tract, causing inflammation of the intestinal walls.

Intestinal fibrosis model (3D)

Lambda's Intestinal Fibrosis Model addresses these challenges by leveraging high mimetic human intestinal organoids to create a model of inflammatory bowel diseases.

Probiotic adhesion assay (2D)

Lambda provides a 2D platform for gut attachment and allows for the evaluation of probiotics efficacy through gut attachment analysis.

Host-Microbiome study (3D)

Lambda's highly human-mimicking intestinal organoids enable realistic research on the gastrointestinal system and interactions between cells and microorganisms, serving as a versatile tool for drug development and disease research.

Drug absorption assay(2D)

Lambda provides drug absorption evaluation through drug (sample) permeability analysis using hPSC-derived human functional intestinal epithelial cells (hIEC).

Cancer Organoid

Ovarian Cancer Organoid

Tailored Tumor Recreation
▶ Our ovarian cancer organoids meticulously mirror individual patient tumors, supporting the formulation of specific treatments.
Enhanced Disease Insight
▶ These organoids serve as precise tools for exploring ovarian cancer dynamics and evaluating potential treatments, crucial for breakthroughs in care.
Optimized Drug Development
▶ Leveraging our ovarian cancer organoids streamlines the evaluation of new therapeutic agents, cutting down on the time and expense involved in advancing clinical solutions.


Organism
Product Type	Organoid
Tissue
Disease	Ovarian Cancer

Applications

Drug Test (Organoid Only)

Establishing a process for isolating cytotoxic T cells that can directly attack cancer cells, creating an MHC-TCR
interaction environment, and utilizing MHC I/II blockers to achieve an immune microenvironment in vivo.

Using Immune Cell Co-culture

Using Cancer Associate Fibroblast

Cancer Organoid

Gastric Cancer Organoid

Patient-Specific Tumor Replication
▶ Our gastric cancer organoids replicate patient-specific tumors by expressing key markers, enabling personalized treatment research.
Advanced Disease Modeling
▶ These organoids offer detailed models for studying tumor behavior and responses to treatments, reflecting actual patient conditions.
Enhanced Drug Screening Efficiency
▶ Using these organoids in drug testing streamlines the process, quickly identifies effective treatments, and reduces research costs and duration


Organism
Product Type
Tissue
Disease	Gastric Cancer

Applications

Drug Test (Organoid Only)

Using Immune Cell Co-culture

Using Cancer Associate Fibroblast

Cancer Organoid

Pancreatic Cancer Organoid

Tumor-Infiltrating Lymphocytes (TILs) are predominantly found in the microenvironment of tumors, including various types of lymphocytes that have infiltrated in and around tumor tissues.
Among them, CD8+ cytotoxic T cells and CD4+ helper T cells are major components.
Our approach involves isolating and expanding TILs from a patient’s tumor tissue, then evaluating the efficacy of anticancer agents in a tumor microenvironment containing cancer organoids and TILs.


Organism
Product Type	Organoid + TIL
Tissue	Pancreatic ducts, Pancreatic endocrine cells
Disease	Pancreatic cancer

Applications

Drug Test (Organoid Only)

Using Immune Cell Co-culture

Using Cancer Associate Fibroblast

Cancer Organoid

Non-Small Cell Lung Cancer Organoid

hLC organoids replicate the characteristics of lung cancer tissue.
They exhibit protein expression patterns of CK5/6, CK7, P40, and TTF-1, allowing for the distinction between different subtypes of lung cancer.
These organoids are useful for studying genetic mutations in lung cancer and testing the efficacy of various chemotherapy treatments.


Organism
Product Type	Organoid
Tissue	Lung alveoli, Bronchi
Disease	Non-Small Cell Lung Cancer

Applications

Drug Test (Organoid Only)

Using Immune Cell Co-culture

Using Cancer Associate Fibroblast

Cancer Organoid

Colorectal Cancer Organoid

hCRC organoids exhibit a three-dimensional structure and cellular composition similar to colorectal cancer tissue.
They express proteins such as CK7, CK20, b-catenin, and CDX2, mirroring the characteristics of colorectal cancer tissue.
These organoids are highly valuable for analyzing genetic mutations in colorectal cancer and evaluating the efficacy of different chemotherapy treatments.


Organism
Product Type	Organoid
Tissue	Colon
Disease	Colorectal cancer

Applications

Oncology

The oncology drug efficacy evaluation platform is based on patient-derived organoids(PDOs).
This platform allows for the assessment of the efficacy of oncology agents and immunotherapeutics by utilizing a co-culture system with immune cells from the tumor microenvironment.

Immuno-Oncology

This provides a solution for assessing the effectiveness of immunotherapeutic agents targeting cytotoxic T cells in co-culture with cancer organoids.

Tumor Microenvironment

CAFs promote cancer invasion and metastasis, potentially inducing resistance to anticancer drugs. Considering these functions of CAFs is crucial for accurately assessing the efficacy of anticancer drugs and developing strategies to address these challenges.

Cancer Vaccine

Lead the future of treatment with our innovative cancer vaccine and mRNA therapy platform! Discover advanced solutions that provide better health and hope through our cutting-edge technology and scientific approach

Cancer Organoid

Cholangiocarcinoma Organoid

hCCA organoids maintain functional characteristics similar to actual cholangiocarcinoma tissue.
They express proteins such as CA19-9, CK7, and CEA, mirroring cholangiocarcinoma tissue.
These organoids are useful for studying genetic mutations in cholangiocarcinoma, testing the efficacy of chemotherapy treatments, and identifying genetic targets for the development of targeted therapies.


Organism
Product Type	Organoid
Tissue	Bile ducts of the liver
Disease	Cholangiocarcinoma

Applications

Drug Test (Organoid Only)

Establishing a process for isolating cytotoxic T cells that can directly attack cancer cells, creating an MHC-TCR interaction environment, and utilizing MHC I/II blockers to achieve an immune microenvironment in vivo.

Using Immune Cell Co-culture

Establishing a process for isolating cytotoxic T cells that can directly attack cancer cells, creating an MHC-TCR interaction environment, and utilizing MHC I/II blockers to achieve an immune microenvironment in vivo.

Using Cancer Associate Fibroblast

Establishing a process for isolating cytotoxic T cells that can directly attack cancer cells, creating an MHC-TCR interaction environment, and utilizing MHC I/II blockers to achieve an immune microenvironment in vivo.

Cancer Organoid

Breast Cancer Organoid

hBC organoids replicate the characteristics of breast cancer tissue.
They express proteins such as ER, PR, and HER2, enabling the identification of specific types like TNBC (Triple-Negative Breast Cancer).
These organoids are useful for studying genetic mutations in breast cancer and evaluating the efficacy of chemotherapy treatments.


Organism
Product Type	Organoid
Tissue	Breast mammary gland, Mammary duct
Disease	Breast cancer

Applications

Drug Test (Organoid Only)

Establishing a process for isolating cytotoxic T cells that can directly attack cancer cells, creating an MHC-TCR interaction environment, and utilizing MHC I/II blockers to achieve an immune microenvironment in vivo.

Using Immune Cell Co-culture

Establishing a process for isolating cytotoxic T cells that can directly attack cancer cells, creating an MHC-TCR interaction environment, and utilizing MHC I/II blockers to achieve an immune microenvironment in vivo.

Using Cancer Associate Fibroblast

Establishing a process for isolating cytotoxic T cells that can directly attack cancer cells, creating an MHC-TCR interaction environment, and utilizing MHC I/II blockers to achieve an immune microenvironment in vivo.